₹1,952.40
+₹23.90 (+1.24%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹49,521 Cr
P/E
36.01
ROE
14.15%
ROCE
18.58%
About Ipca Laboratories Ltd
Ipca Laboratories is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and Active Pharmaceutical Ingredients (APIs). The Company is an integrated pharmaceutical company manufacturing and marketing.
Founded
1949
CEO
Premchand Godha
Employees
23,467
HQ
Mumbai, India
About Ipca Laboratories Ltd
Ipca Laboratories is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and Active Pharmaceutical Ingredients (APIs). The Company is an integrated pharmaceutical company manufacturing and marketing.
Founded:1949
CEO:Premchand Godha
Employees:23,467
HQ:Mumbai, India
Finished Products
1Sale of Products
₹20,014.67Cr2Export Incentive
₹52.25Cr3Scrap Sale
₹50.09Cr4Sale of Services
₹42.20Cr5Miscellaneous Income
₹20.24Cr6Sundry Balances W/back
₹1.68CrRaw Materials
1Raw Materials Consumed
₹3,950.22Cr2Formulations
₹993.86Cr3Packing Materials
₹803.50Cr4Active Pharma.Ingredients/Inte
₹47.10Cr5Neutralisation of Duties & Tax
₹-79.39CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,992
52W Low
₹1,252
Volume455.43K
Avg VolumeN/A
Beta0.01
Dividend Yield0.31%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
36.01x
Valuation
P/B Ratio
6.14x
Valuation
EPS
₹54.20
Valuation
Dividend Yield
0.31%
Valuation
ROE
14.15%
Profitability
ROCE
18.58%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
45.5%
International
54.5%
Outside India54.5%
India45.5%
Strategic Relations
Collaborations, joint ventures & subsidiaries
C
Central Drug Research Institute
India
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.10x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
7.8%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.